Samuel J. Bullers

Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease

Nathaniel R. West, Ahmed N. Hegazy, Benjamin M. J. Owens et al. · Nature Medicine · 2017 · 805 citations · Full text

Medicine, Immunology, Oncology +17

IL-1-driven stromal–neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies

Matthias Friedrich, Mathilde Pohin, Matthew Jackson et al. · Nature Medicine · 2021 · 290 citations · Full text

Veterinary Medicine, Immunology, Pathology +17

A Large Polysaccharide Produced by Helicobacter hepaticus Induces an Anti-inflammatory Gene Signature in Macrophages

Camille Danne, Grigory Ryzhakov, María Martínez‐López et al. · Cell Host & Microbe · 2017 · 120 citations · Full text

Life Sciences, Immunology, Microbiology +17

Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice

Lin Wang, Dominik Aschenbrenner, Zhiyang Zeng et al. · Nature Genetics · 2021 · 108 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

Alpha kinase 1 controls intestinal inflammation by suppressing the IL-12/Th1 axis

Grigory Ryzhakov, Nathaniel R. West, Fanny Franchini et al. · Nature Communications · 2018 · 63 citations · Full text

Life Sciences, Immunology, Molecular Genetics +17